VP
Therapeutic Areas
numares Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AGILE 3 | Risk of rapid progression in early Chronic Kidney Disease (CKD) | Approved |
| Cardiovascular Disease Tests | Heart Failure with preserved Ejection Fraction (HFpEF), Acute Coronary Syndrome | Development/Validation |
| Companion Diagnostics | Various metabolic & renal drug candidates | Discovery/Development |